Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZL0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,329
Award facts
- Contract value 100% obligated
- $77,328.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $77,328.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on February 4, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status and extensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's prime vendor contract under PPV-G GEN V, valued at $499,999,999 and extending through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products to support recurring medical supply needs of military healthcare facilities worldwide. The award of this Trikafta delivery order exemplifies the contractor's sustained performance in fulfilling the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCZL0?
SPE2DR26FCZL0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FCZL0 worth?
The government has obligated $77,329 on SPE2DR26FCZL0.
Is contract SPE2DR26FCZL0 an order under another contract?
Yes. SPE2DR26FCZL0 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZL0 competed?
The extent of competition for SPE2DR26FCZL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award